209 related articles for article (PubMed ID: 34944022)
1. NT1-Tau Is Increased in CSF and Plasma of CJD Patients, and Correlates with Disease Progression.
Mengel D; Mok TH; Nihat A; Liu W; Rissman RA; Galasko D; Zetterberg H; Mead S; Collinge J; Walsh DM
Cells; 2021 Dec; 10(12):. PubMed ID: 34944022
[TBL] [Abstract][Full Text] [Related]
2. Plasma NT1 Tau is a Specific and Early Marker of Alzheimer's Disease.
Mengel D; Janelidze S; Glynn RJ; Liu W; Hansson O; Walsh DM
Ann Neurol; 2020 Nov; 88(5):878-892. PubMed ID: 32829532
[TBL] [Abstract][Full Text] [Related]
3. CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD.
Blennow K; Diaz-Lucena D; Zetterberg H; Villar-Pique A; Karch A; Vidal E; Hermann P; Schmitz M; Ferrer Abizanda I; Zerr I; Llorens F
J Neurol Neurosurg Psychiatry; 2019 Aug; 90(8):846-853. PubMed ID: 31097472
[TBL] [Abstract][Full Text] [Related]
4. Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease.
Abu-Rumeileh S; Baiardi S; Ladogana A; Zenesini C; Bartoletti-Stella A; Poleggi A; Mammana A; Polischi B; Pocchiari M; Capellari S; Parchi P
J Neurol Neurosurg Psychiatry; 2020 Nov; 91(11):1181-1188. PubMed ID: 32928934
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic value of plasma neurofilament light and total-tau in sporadic Creutzfeldt-Jakob disease.
Zerr I; Villar-Piqué A; Hermann P; Schmitz M; Varges D; Ferrer I; Riggert J; Zetterberg H; Blennow K; Llorens F
Alzheimers Res Ther; 2021 Apr; 13(1):86. PubMed ID: 33883011
[TBL] [Abstract][Full Text] [Related]
6. Serum tau protein as a marker for the diagnosis of Creutzfeldt-Jakob disease.
Noguchi-Shinohara M; Hamaguchi T; Nozaki I; Sakai K; Yamada M
J Neurol; 2011 Aug; 258(8):1464-8. PubMed ID: 21360196
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and Prognostic Value of Plasma GFAP in Sporadic Creutzfeldt-Jakob Disease in the Clinical Setting of Rapidly Progressive Dementia.
Bentivenga GM; Baiardi S; Mastrangelo A; Zenesini C; Mammana A; Rossi M; Polischi B; Capellari S; Parchi P
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791145
[TBL] [Abstract][Full Text] [Related]
8. The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias.
Abu-Rumeileh S; Capellari S; Stanzani-Maserati M; Polischi B; Martinelli P; Caroppo P; Ladogana A; Parchi P
Alzheimers Res Ther; 2018 Jan; 10(1):3. PubMed ID: 29368621
[TBL] [Abstract][Full Text] [Related]
9. Total and Phosphorylated Cerebrospinal Fluid Tau in the Differential Diagnosis of Sporadic Creutzfeldt-Jakob Disease and Rapidly Progressive Alzheimer's Disease.
Hermann P; Haller P; Goebel S; Bunck T; Schmidt C; Wiltfang J; Zerr I
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215868
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of surrogate CSF biomarkers for Creutzfeldt-Jakob disease in the era of RT-QuIC.
Abu-Rumeileh S; Baiardi S; Polischi B; Mammana A; Franceschini A; Green A; Capellari S; Parchi P
J Neurol; 2019 Dec; 266(12):3136-3143. PubMed ID: 31541342
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Aβ42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants.
Abu Rumeileh S; Lattanzio F; Stanzani Maserati M; Rizzi R; Capellari S; Parchi P
J Alzheimers Dis; 2017; 55(4):1471-1480. PubMed ID: 27886009
[TBL] [Abstract][Full Text] [Related]
12. Plasma and cerebrospinal fluid tau and neurofilament concentrations in rapidly progressive neurological syndromes: a neuropathology-based cohort.
Kovacs GG; Andreasson U; Liman V; Regelsberger G; Lutz MI; Danics K; Keller E; Zetterberg H; Blennow K
Eur J Neurol; 2017 Nov; 24(11):1326-e77. PubMed ID: 28816001
[TBL] [Abstract][Full Text] [Related]
13. Stratification by Genetic and Demographic Characteristics Improves Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers in Rapidly Progressive Dementia.
Karch A; Llorens F; Schmitz M; Arora AS; Zafar S; Lange P; Schmidt C; Zerr I
J Alzheimers Dis; 2016 Oct; 54(4):1385-1393. PubMed ID: 27589519
[TBL] [Abstract][Full Text] [Related]
14. Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels.
Lattanzio F; Abu-Rumeileh S; Franceschini A; Kai H; Amore G; Poggiolini I; Rossi M; Baiardi S; McGuire L; Ladogana A; Pocchiari M; Green A; Capellari S; Parchi P
Acta Neuropathol; 2017 Apr; 133(4):559-578. PubMed ID: 28205010
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease cerebrospinal fluid biomarkers differentiate patients with Creutzfeldt-Jakob disease and autoimmune encephalitis.
Chang BK; Day GS; Graff-Radford J; McKeon A; Flanagan EP; Algeciras-Schimnich A; Mielke MM; Nguyen A; Jones DT; Toledano M; Kremers WK; Knopman DS; Petersen RC; Li W
Eur J Neurol; 2022 Oct; 29(10):2905-2912. PubMed ID: 35735602
[TBL] [Abstract][Full Text] [Related]
16. Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease.
Dorey A; Tholance Y; Vighetto A; Perret-Liaudet A; Lachman I; Krolak-Salmon P; Wagner U; Struyfs H; De Deyn PP; El-Moualij B; Zorzi W; Meyronet D; Streichenberger N; Engelborghs S; Kovacs GG; Quadrio I
JAMA Neurol; 2015 Mar; 72(3):267-75. PubMed ID: 25559883
[TBL] [Abstract][Full Text] [Related]
17. Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein.
Grangeon L; Paquet C; Bombois S; Quillard-Muraine M; Martinaud O; Bourre B; Lefaucheur R; Nicolas G; Dumurgier J; Gerardin E; Jan M; Laplanche JL; Peoc'h K; Hugon J; Pasquier F; Maltête D; Hannequin D; Wallon D;
J Alzheimers Dis; 2016; 51(3):905-13. PubMed ID: 26890785
[TBL] [Abstract][Full Text] [Related]
18. Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease.
Chen Z; Mengel D; Keshavan A; Rissman RA; Billinton A; Perkinton M; Percival-Alwyn J; Schultz A; Properzi M; Johnson K; Selkoe DJ; Sperling RA; Patel P; Zetterberg H; Galasko D; Schott JM; Walsh DM
Alzheimers Dement; 2019 Mar; 15(3):487-496. PubMed ID: 30419228
[TBL] [Abstract][Full Text] [Related]
19. Neurofilament light chain and tau concentrations are markedly increased in the serum of patients with sporadic Creutzfeldt-Jakob disease, and tau correlates with rate of disease progression.
Thompson AGB; Luk C; Heslegrave AJ; Zetterberg H; Mead SH; Collinge J; Jackson GS
J Neurol Neurosurg Psychiatry; 2018 Sep; 89(9):955-961. PubMed ID: 29487167
[TBL] [Abstract][Full Text] [Related]
20. Highly increased CSF tau protein and decreased beta-amyloid (1-42) in sporadic CJD: a discrimination from Alzheimer's disease?
Kapaki E; Kilidireas K; Paraskevas GP; Michalopoulou M; Patsouris E
J Neurol Neurosurg Psychiatry; 2001 Sep; 71(3):401-3. PubMed ID: 11511720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]